4//SEC Filing
Rubenstein David M. 4
Accession 0001127602-24-021791
CIK 0001682852other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:06 PM ET
Size
12.0 KB
Accession
0001127602-24-021791
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Rubenstein David M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-05+5,051→ 5,051 totalExercise: $83.75Exp: 2034-08-05→ Common Stock (5,051 underlying) - Award
Restricted Stock Units
2024-08-05+677→ 677 total→ Common Stock (677 underlying) - Award
Restricted Stock Units
2024-08-05+850→ 850 total→ Common Stock (850 underlying) - Award
Stock Option (Right to Buy)
2024-08-05+4,065→ 4,065 totalExercise: $83.75Exp: 2034-08-05→ Common Stock (4,065 underlying)
Footnotes (5)
- [F1]This option will become fully vested and exercisable on August 5, 2025.
- [F2]This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
- [F3]Restricted stock units convert into common stock on a one-for-one basis.
- [F4]The shares subject to this restricted stock unit award will vest in full on August 5, 2025.
- [F5]The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001543895
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:06 PM ET
- Size
- 12.0 KB